Brief: Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
Deciphera Pharmaceuticals Inc DCPH.O :
* DECIPHERA PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023
FINANCIAL
RESULTS
* Q1 EARNINGS PER SHARE VIEW $-0.59, REVENUE VIEW $35.8
MILLION --
REFINITIV IBES DATA
* DECIPHERA PHARMACEUTICALS - EXPECTS CURRENT CASH, CASH
EQUIVALENTS, MARKETABLE SECURITIES TO ENABLE CO TO FUND
OPERATING & CAPEX INTO 2026
Source text for Eikon: ID:nBw8hg5Sha
Further company coverage: DCPH.O
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions